Bicycle Therapeutics (BCYC) Depreciation & Amortization (CF) (2018 - 2026)

Bicycle Therapeutics has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 30.91% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $5.9 million (down 17.24% YoY), and the FY2025 full-year result was $6.4 million, down 10.48% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $2.2 million in Q3 2024, with the low at $422000.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 275.07% — and 2026, when it sank 30.91%.
• Bicycle Therapeutics' Depreciation & Amortization (CF) stood at $1.4 million in 2022, then climbed by 19.34% to $1.7 million in 2023, then increased by 3.02% to $1.7 million in 2024, then declined by 21.6% to $1.3 million in 2025, then slipped by 15.49% to $1.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.